BioNTech SE at Jefferies Healthcare Conference (Virtual) Transcript
Hello and thank you. Welcome to the 2021 Jefferies Global Healthcare Conference. My name is Kelechi Chikere and I am a senior member of the Jefferies Biotech team.
It is with great pleasure that I introduce the Chief Strategy Officer of BioNTech, Ryan Richardson. BioNTech has had a really stunning and transformational 2020, 2021, with a number of developments across various programs, including their leading COVID-19 vaccine, and progress across their multiple oncology programs.
Now, I guess, before we get started with some of the fireside questions, on a high level, Ryan, can you provide an overview of BioNTech, current programs, and I guess some of the events and updates that you're specifically excited about over the next 6 to 12 months, I guess?
Sure. And first of all, thank you for the invitation, Kelechi. It's great to be with you. And I will be making some forward-looking statements today. So BioNTech is a fully integrated immunotherapy company focused on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
